Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€259.70
Performance (%)
-12.12%
Price
24.05.24
€200.20
Summary
This prediction is currently active. The prediction for Charles River Labs Intl disappoints with a performance of -12.12%. This prediction currently runs until 15.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -1.815% | -1.815% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€211.90
20.12.23
20.12.23
€246.65
20.12.24
20.12.24
-5.52%
24.05.24
24.05.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€198.20
10.08.23
10.08.23
€227.00
10.08.24
10.08.24
1.01%
24.05.24
24.05.24